Here are four recent cardiology procedures that were the first-of-their-kind or the first in the state they were performed in, as reported by Becker's: ...

A medical milestone has been achieved in Deep East Texas as the first Left Atrial Appendage Occlusion (LAAO) procedure ...

Boston Scientific expects its Cardiovascular segment to continue its growth stride. Its POLARx and WATCHMAN FLX Pro Left Atrial Appendage Closure devices received robust market responses after FDA ...

The Farapulse PFA system provides a non-thermal approach for ablating heart tissue related to atrial fibrillation.

Boston Scientific achieves PMDA approval for its FARAPULSE PFA System in Japan. The company expects to launch the system in the country in the upcoming weeks.

Taiwan and Hong Kong in early 2025 to study the safety and efficacy of concomitant procedures using the FARAPULSE PFA System for cardiac ablation and the WATCHMAN FLX Pro Left Atrial Appendage Closure ...

Strong worldwide demand for its Electrophysiology and Structural Heart lines, traction in Europe for its next-generation WATCHMAN FLX, as well as contributions from accretive acquisitions are ...

Boston Scientific Corporation (NYSE: BSX) announced it has received Pharmaceuticals and Medical Device Agency (PMDA) approval in Japan for the FARAPULSE™ Pulsed Field Ablation (PFA) System. The ...